Clinical Trials Browser

OTHER × Has results × HuMax-IL8 × Clear all

NCT04050462 2025-10-16

Nivolumab Combined With BMS-986253 in HCC Patients

Phase 2 Terminated

13 enrolled 13 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT04347226 2025-05-22

Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19

Phase 2 Terminated

43 enrolled 14 charts

Other hematologic neoplasm

COVID-19, Coronavirus Infections, Hematologic Neoplasms

NCT03689699 2025-04-29

Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)

Phase 1/2 Active not recruiting

59 enrolled 9 charts

Prostatic Neoplasms